ASCO: Entrectinib gets edge over crizotinib against ROS1+ lung cancer
Credit: University of Colorado Cancer Center Crizotinib and entrectinib are both active against ROS1+ non-small cell lung cancer. But which ...
Credit: University of Colorado Cancer Center Crizotinib and entrectinib are both active against ROS1+ non-small cell lung cancer. But which ...
Credit: LSU Health New Orleans New Orleans, LA - Research led by Ashok Aiyar, PhD, Associate Professor of Microbiology, Immunology ...
First award recipients of $50 Million research program -- created to address urgent need for rapid, affordable, and easy-to-use diagnostic ...
Study is first state-wide investigation of cannabis use among older Americans and the outcomes they experience AURORA, Colo. (May 30, ...
CHICAGO (May 30, 2019) -- A questionnaire aimed at assessing how well community oncologists understand "molecular profiling" results from tumor ...
Credit: James Shewaga, University of Saskatchewan Concussion symptoms--such as loss of balance, hazy comprehension, sleep disturbance and ability to walk ...
Study shows that extensive testing doesn't help predict major cardiac eventsCredit: UC Regents / UC Davis Health Most patients seen ...
Better support of older adults' care needs could offset Medicare spending A new study from researchers at the Johns Hopkins ...
On May 24, the Food and Drug Administration approved Zolgensma®, a gene therapy drug for the treatment of spinal muscular ...
Université de Montréal's Laboratory of Biosensors & Nanomachines, in partnership with Montreal company Nanogenecs Diagnostics, has just been awarded a ...
Credit: Justin Ohata/UBC Faculty of Pharmaceutical Sciences For many people with chronic obstructive pulmonary disease or COPD, a steroid inhaler ...
Canada should reinvent the Motherisk program to support pregnant women to have healthy babies, argues an editorial in CMAJ (Canadian ...
Licorice tea, a popular herbal tea, is not without health risks, as a case study of a man admitted to ...
Despite potential for prolonging survival with treatment, one-third of patients with metastatic pancreatic cancer do not see a medical oncologist, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.